首页> 外国专利> METHOD FOR PREDICTING RESUMPTION OF CORONARY HEART DISEASE CLINICAL PICTURE BY MEANS OF NEURAL NETWORKS IN PATIENTS AFTER ENDOVASCULAR INTERVENTION

METHOD FOR PREDICTING RESUMPTION OF CORONARY HEART DISEASE CLINICAL PICTURE BY MEANS OF NEURAL NETWORKS IN PATIENTS AFTER ENDOVASCULAR INTERVENTION

机译:血管内介入治疗后患者神经网络预测冠心病临床影像恢复的方法

摘要

FIELD: medicine.;SUBSTANCE: invention relates to medicine, namely to cardiology and cardiac surgery, and can be used to predict the resumption of coronary heart disease clinical picture after endovascular intervention. State of the hemostatic system is determined by the Thrombin generation assay (TGA) in two parallel settings. One formulation without the addition of thrombomodulin (- rh-TM), and the other formulation with the addition of thrombomodulin (+ rh-TM). In each formulation, the time of initiation of LT coagulation (Lag Time), Peak thrombin concentration (Peak thrombin), time to reach peak trombin ttPeak (time to peak) concentrations and Endogenous Thrombin Potential endogenous potential are determined. Calculate the rate of formation of thrombin according to the claimed formula. Then, using neural networks, ETP, Peak, VI_TM and % LT programmed in the Mathematica Wolfram package are analyzed. Determine the personal rate of each patient. If the personal coefficient is in the range from 0.10 to 3.35, the risk of recurrence of coronary disease is considered minimal. If the personal coefficient is in the range from – 0.02 to – 4.58, the risk of recurrence of coronary disease is considered maximum.;EFFECT: method allows to increase the prognostic accuracy of the test results of the generation of thrombin in predicting the resumption of the clinic of coronary heart disease in patients after endovascular intervention, identify patients with high risk and provide an individual approach to the management of patients with high risk, increase the effectiveness of treatment through the use of neural networks and assess the complex of the most significant indicators.;1 cl, 1 dwg, 3 tbl
机译:药物领域:发明领域本发明涉及医学,即心脏病学和心脏外科手术,可用于预测血管内介入治疗后冠心病临床表现的恢复。通过凝血酶生成测定法(TGA)在两个平行设置中确定止血系统的状态。一种制剂不添加血栓调节蛋白(-rh-TM),另一种制剂不添加血栓调节蛋白(+ rh-TM)。在每种制剂中,确定了LT凝血的起始时间(滞后时间),峰值凝血酶浓度(峰值凝血酶),达到峰值血栓素浓度ttPeak(到达峰值的时间)的时间以及内源性凝血酶潜在内源性电位。根据要求的公式计算凝血酶的形成速率。然后,使用神经网络分析在Mathematica Wolfram软件包中编程的ETP,Peak,VI_TM和%LT。确定每个患者的个人费率。如果个人系数在0.10到3.35之间,则认为冠心病复发的风险极小。如果个人系数在– 0.02至– 4.58的范围内,则认为冠心病复发的风险最大。;效果:该方法可提高凝血酶生成的检测结果的预后准确性,以预测凝血酶的恢复进行血管内介入治疗后的冠心病患者诊所,识别高危患者并提供个性化的高危患者管理方法,通过使用神经网络提高治疗效果并评估最重要的复杂因素指标。; 1 cl,1 dwg,3 tbl

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号